DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
Elan Corporation PLC (ELN) Announces Pricing of $850 Million in Aggregate Principal Amount of Senior Notes Due 2021 5/24/2013  More...
3SBio Inc. (SSRX)'s Shareholders Approve Go-Private Transaction 5/24/2013  More...
Jennerex, Inc. Completes $21.6 Million Private Placement 5/23/2013  More...
Apricus Biosciences (APRI) Prices $17.1 Million Public Offering of Common Stock and Warrants 5/23/2013  More...
Stemline Therapeutics, Inc. (STML) Announces Exercise of Option to Purchase Additional Shares 5/23/2013  More...
Zealand Pharma - Announcement of Transactions in the Company’s Shares and Related Securities by Executives and Their Related Parties 5/23/2013  More...
Apricus Biosciences (APRI) Announces Proposed Public Offering of Common Stock and Warrants 5/23/2013  More...
BioTime (BTX) Announces Results of Vote at Special Meeting of Shareholders 5/23/2013  More...
Advaxis, Inc. Announces Filing of Proxy Statement Supplement and New Annual Meeting Date 5/23/2013  More...
Portola Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering 5/23/2013  More...
Merck & Co., Inc. (MRK) Signs $5 Billion Share Buyback Agreement With Goldman, Sachs & Co. 5/22/2013  More...
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Closing of Underwritten Offering 5/22/2013  More...
Stemline Therapeutics, Inc. (STML) Announces Closing of $60 Million Public Offering of Common Stock 5/22/2013  More...
H. Lundbeck A/S (LUN.CO) – Admittance to Trading and Official Listing of New Shares Due to Exercise of Warrants 5/21/2013  More...
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - March 2013 5/21/2013  More...
Royalty Pharma Increases Offer for Elan Corporation PLC (ELN) to $12.50 Per Share in All Cash 5/21/2013  More...
Landauer (LDR) Declares Regular Cash Dividend 5/21/2013  More...
NPS Pharmaceuticals, Inc. (NPSP) Announces Proposed Public Offering of 6,000,000 Shares of Its Common Stock 5/21/2013  More...
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock 5/21/2013  More...
BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5/20/2013  More...
Progenics Pharmaceuticals, Inc. (PGNX) Added to the NASDAQ Biotechnology Index 5/20/2013  More...
ACADIA Pharmaceuticals, Inc. (ACAD) Added to NASDAQ Biotechnology Index 5/20/2013  More...
CytRx Corporation (CYTR) Issues Letter to Stockholders Providing Business Update 5/20/2013  More...
Prima Biomed (PRR.AX) Issues the Following Notice to Stockholders of the Company 5/20/2013  More...
Digirad Corporation (DRAD) Rejects Dissident's Call for New Stockholder Meeting as Yet Another Attempt to Seize Control of the Company 5/20/2013  More...
TNI BioTech's CEO Issues Letter to Shareholders Discussing Recent Events 5/17/2013  More...
Stemline Therapeutics, Inc. (STML) Prices $60 Million Public Offering of Common Stock 5/17/2013  More...
Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI) 5/17/2013  More...
Vertex Pharmaceuticals (MA) (VRTX) Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015 5/17/2013  More...
Bristol-Myers Squibb Company (BMY) Announces Intention to Voluntarily Delist Preferred Stock 5/17/2013  More...
Oxygen Biotherapeutics, Inc. (OXBO) Receives Favorable NASDAQ Listing Decision 5/17/2013  More...
PURE Bioscience (PURE) Stock to Begin Trading on the OTCQB Marketplace 5/17/2013  More...
Galapagos NV (GLPG.BR) Creates New Warrant Plan 5/17/2013  More...
VIVUS, Inc. (VVUS) Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes 5/16/2013  More...
Lundbeck Inc. (LUN.CO) Increases its Share Capital by 9,772 Shares (0.005% of Outstanding Shares) as a Result of Employee Warrant Exercise 5/16/2013  More...
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces $20 Million Underwritten Offering 5/16/2013  More...
Annual General Meeting of Active Biotech AB (BTPC) 5/16/2013  More...
Bavarian Nordic (BAVA.CO) - Interim Financial Report for the Period 1 January to 31 March 2013 5/16/2013  More...
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Proposed Public Offering of Common Stock 5/16/2013  More...
Oxygen Biotherapeutics, Inc. (OXBO) Receives Favorable NASDAQ Listing Decision 5/16/2013  More...
Elan Corporation PLC (ELN) Announces Publication of Response Document 5/16/2013  More...
Santarus Inc. (SNTS) Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering 5/16/2013  More...
Merck & Co., Inc. (MRK) Prices $ 6.5 Billion Debt Offering 5/16/2013  More...
Rockwell Medical Technologies (RMTI) Prices $35.0 Million Public Offering of Common Stock 5/15/2013  More...
VIVUS, Inc. (VVUS) Announces Proposed Offering of Convertible Senior Notes 5/15/2013  More...
Discovery Laboratories (DSCO) Announces Completion of $14.25 Million Public Offering 5/15/2013  More...
Fibrocell Science, Inc. Announces Approval of Common Stock Listing on NYSE MKT 5/15/2013  More...
ACADIA Pharmaceuticals, Inc. (ACAD) Prices Public Offering of Common Stock 5/15/2013  More...
Sucampo Pharmaceuticals, Inc. (SCMP) to be Added to the NASDAQ Biotechnology Index 5/15/2013  More...
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Proposed Public Offering of Common Stock 5/15/2013  More...
BioAmber Inc. Announces Closing of Initial Public Offering 5/15/2013  More...
TopoTarget A/S Release: Shareholder Meetings in Copenhagen and Aarhus 5/14/2013  More...
Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index 5/14/2013  More...
RegeneRx Biopharmaceuticals, Inc. (RGRX) Issues Letter to Sharholders 5/14/2013  More...
Omeros Corporation (OMER) Announces Closing of $16.2 Million Registered Direct Offering of Common Stock 5/14/2013  More...
SIGA Technologies, Inc. (SIGA) Announces Restatement of Certain Historical Financial Results to Reflect Reclassification of Warrants as a Liability 5/13/2013  More...
Warner Chilcott, PLC (WCRX) Release: Announcement Under Irish Takeover Rules Relevant Securities in Issue 5/13/2013  More...
Discovery Laboratories (DSCO) Announces Proposed Public Offering of Common Stock 5/10/2013  More...
Omeros Corporation (OMER) Announces $16.2 Million Registered Direct Offering of Common Stock 5/10/2013  More...
Pain Therapeutics (PTIE) Files Form 8-K Regarding Correspondence From Pfizer Inc. (PFE) 5/10/2013  More...
BioAmber Inc. Announces Pricing of Initial Public Offering 5/10/2013  More...
Karolinska Development AB - Interim Report January - March 2013 5/10/2013  More...
NeoStem, Inc. Clarification: No New Securities Being Issued 5/10/2013  More...
Santarus Inc. (SNTS) Announces Launch of a Proposed Secondary Common Stock Offering by a Selling Stockholder 5/10/2013  More...
Aceto Corporation Board of Directors Declares Quarterly Cash Dividend 5/10/2013  More...
NeoStem, Inc. CEO's Letter to Shareholders 5/10/2013  More...
Oxygen Biotherapeutics, Inc. (OXBO) Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th 5/10/2013  More...
Santarus Inc. (SNTS) Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder 5/10/2013  More...
Immunotech Laboratories Corporate Shareholder Update Summary 5/9/2013  More...
AEterna Zentaris (AEZS) Announces Election of Directors at Its Annual Meeting of Shareholders 5/9/2013  More...
MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ 5/9/2013  More...
Receptos Announces Pricing of Initial Public Offering of Common Stock 5/9/2013  More...
BioSante Pharmaceuticals, Inc. (BPAX) and ANI Pharmaceuticals, Inc. Announce Special Meetings of Stockholders to Consider Proposed Merger 5/9/2013  More...
Sonomax Technologies Announces Listing on the CNSX 5/9/2013  More...
IntelGenx Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan 5/9/2013  More...
Isis Pharmaceuticals, Inc. (ISIS) Prices Public Offering of Common Stock 5/9/2013  More...
Zealand Pharma Announces Amendments to its Articles of Association 5/8/2013  More...
Notice of Zealand Pharma ’s Interim Report for Q1 2013 5/8/2013  More...
Isis Pharmaceuticals, Inc. (ISIS) Announces Proposed Public Offering of Common Stock 5/8/2013  More...
Bayer HealthCare (BAY) Commences Cash Tender Offer for All Outstanding Shares of Conceptus, Inc. (CPTS) 5/8/2013  More...
Sigma-Aldrich Corporation (SIAL) Declares $0.215 Per Share Quarterly Dividend 5/8/2013  More...
GW Pharmaceuticals Announces the Closing of Its Initial Public Offering on the Nasdaq Global Market 5/8/2013  More...
Warner Chilcott, PLC (WCRX) Declares Semi-Annual Cash Dividend of $0.25 Per Share 5/8/2013  More...
DiaGenic ASA: Increase in Share Capital 5/8/2013  More...
Idera Pharmaceuticals, Inc. (IDRA) Announces Closing of Common Share Offering 5/8/2013  More...
Nuvo Research Inc. (NRI.TO) to Complete Share Consolidation 5/7/2013  More...
Karolinska Development AB - Interim Report January - March, Invitation to Conference Call Friday, May 10 5/7/2013  More...
INSYS Therapeutics Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option 5/7/2013  More...
Lignol Provides Addional Funding to Territory Biofuels Limited to Obtain Fully Diluted Majority Interest 5/6/2013  More...
Change in the Number of Votes Relating to BioTie Therapies Corp.'s Shares 5/6/2013  More...
PledPharma Appoints Advisor for the Commercialization of PledOx® 5/6/2013  More...
Novo Nordisk A/S (NVO) - Share Repurchase Program 5/6/2013  More...
Adamis Pharmaceuticals CEO Provides Update for Shareholders 5/6/2013  More...
3SBio Inc. (SSRX) Schedules Take-Private Vote for May 24 5/3/2013  More...
LipoScience, Inc. to Release First Quarter Fiscal Year 2013 Financial Results 5/3/2013  More...
Myriad Genetics, Inc. (MYGN) Announces 2013 Analyst and Investor Day 5/3/2013  More...
Kythera Biopharmaceuticals to Release First Quarter 2013 Operating Results 5/3/2013  More...
ChemoCentryx, Inc. (CCXI) to Hold First Quarter 2013 Financial Results Conference Call on Monday, May 13, 2013 5/3/2013  More...
PRANA Biotechnology (PRAN) Announces Share Purchase Plan Closed 5/3/2013  More...
Sanofi (France) (SAN.PA): Q1 2013 Business EPS(1) Impacted by Exclusivity Losses in Prior Year 5/2/2013  More...
3SBio Inc. (SSRX) Files Annual Report on Form 20-F for Fiscal Year 2012 5/2/2013  More...
Merck & Co., Inc. (MRK) Sales Disappoint; Company Cuts Profit Outlook 5/1/2013  More...
Sinovac Biotech Ltd. (SVA) Files Annual Report on Form 20-F 5/1/2013  More...
DW Healthcare Partners Invests in Med-Pharmex, Inc. 5/1/2013  More...
Stock House Group Report Initiates Coverage on Plandai Biotechnology, Inc. (PLPL.OB) 5/1/2013  More...
Coronado Biosciences to Report First Quarter 2013 Financial Results 5/1/2013  More...
Polydex Pharmaceuticals (POLXF) Reports Strong Backlog Resulting From Worldwide Increase in Demand for Product in 2013 Fiscal Year End Financial Results 5/1/2013  More...
NeoStem, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option 5/1/2013  More...
Idenix Pharmaceuticals, Inc. (IDIX) Reports First Quarter 2013 Financial Results 5/1/2013  More...
Mela Sciences (MELA) Announces First Quarter 2013 Financial Results 5/1/2013  More...
Amyris, Inc. Reports First Quarter 2013 Financial Results 5/1/2013  More...
Chrontech Pharma AB Receives Extended Offer From a Group of Shareholder 4/30/2013  More...
NYSE Liffe Lists Equity Options on Galapagos NV (GLPG.BR) 4/30/2013  More...
Novo Nordisk A/S (NVO) - Share Repurchase Program 4/30/2013  More...
Total Number of Voting Rights and Share Capital in Novo Nordisk A/S (NVO) as of 30 April 2013 4/30/2013  More...
Techne Corp. (TECH) Declares Dividend 4/30/2013  More...
Merrimack Pharmaceuticals Inc. Announces Timing of First Quarter 2013 Investor Conference Call 4/30/2013  More...
Momenta Pharmaceuticals, Inc. (MNTA) Reports First Quarter 2013 Financial Results 4/30/2013  More...
Cleveland Biolabs Inc. (CBLI) to Report First Quarter 2013 Financial Results and Provide Operational Update on May 9 4/30/2013  More...
Medical Marijuana, Inc. Shareholder Update and Letter 4/30/2013  More...
Aegerion Pharmaceuticals, Inc. (AEGR) Announces First-Quarter 2013 Financial Results 4/30/2013  More...
Bioniche Life Sciences Inc. (BNC) Acknowledges Request for Shareholder Meeting 4/29/2013  More...
GENFIT Corp. (ALGFT): Conversions Into Shares of 30 Bonds OCA2012-2 4/29/2013  More...
iBio, Inc. (IBIO) Closes $4.2 Million Public Offering and Terminates at-the-Market Offering 4/29/2013  More...
Neovasc Inc. (NVC) Reports Financial Results for 2012 Year-End 4/29/2013  More...
Galapagos NV (GLPG.BR) Completes Private Placement by Issuance of 2,696,831 New Ordinary Shares 4/29/2013  More...
Digirad Corporation (DRAD) Urges Stockholders to Vote the WHITE Proxy Card to Support Digirad's Director Nominees 4/26/2013  More...
Anacor Pharmaceuticals, Inc. (ANAC) Prices $20 Million Public Offering of Common Stock 4/26/2013  More...
Biotage AB (BIOTa.ST) Launches Share Buy-Back 4/26/2013  More...
Supernus Pharmaceuticals (SUPN) Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019 4/26/2013  More...
PURE Bioscience (PURE) Receives Favorable NASDAQ Listing Decision 4/25/2013  More...
Nuvilex Price Valuation Justifies Investors' Confidence in Biotech 4/25/2013  More...
3SBio Inc. (SSRX) Adjourns Extraordinary General Meeting of Shareholders 4/25/2013  More...
Pfizer Inc. (PFE) Hosts Annual Meeting of Shareholders 4/25/2013  More...
Galapagos NV (GLPG.BR) to Raise Capital Via a Private Placement of New Shares 4/24/2013  More...
Haemonetics Corporation (HAE) Sets Date for Investor/Analyst Meeting 4/24/2013  More...
DURECT Corporation (DRRX) Invites You to Join Its First Quarter 2013 Earnings Conference Call 4/24/2013  More...
Navidea Biopharmaceuticals (NAVB) Announces Underwritten Sale of Common Stock 4/24/2013  More...
Pain Therapeutics (PTIE) Reports Q1 2013 Financial Results 4/24/2013  More...
Sagent Pharmaceuticals, Inc. Sets Date and Time for Release of First Quarter 2013 Financial Results 4/24/2013  More...
iBio, Inc. (IBIO) Prices $4.2 Million Public Offering 4/23/2013  More...
Medicago, Inc. Announces a $3.5 Million Private Placement 4/23/2013  More...
iBio, Inc. (IBIO) Announces Proposed Public Offering 4/23/2013  More...
Novo Nordisk A/S (NVO) - Share Repurchase Program 4/22/2013  More...
Novo Nordisk A/S (NVO): Reduction of the Share Capital 4/22/2013  More...
Ablynx Announces Warrant Exercise 4/22/2013  More...
MorphoSys AG to Start Share Buy-Back Program 4/22/2013  More...
TherapeuticsMD, Inc. Announces Trading of Its Common Stock on the NYSE MKT Under Symbol "TXMD" 4/22/2013  More...
CorMedix (CRMD) Granted Extension of NYSE MKT Listing 4/22/2013  More...
Endocyte, Inc. (ECYT) Announces First Quarter 2013 Earnings Conference Call 4/19/2013  More...
Victory Park Capital Completes Public Auction of Unigene Laboratories, Inc. (UGNE)'s Peptelligence™ Drug Delivery Platform 4/18/2013  More...
Siegfried's Annual Shareholders Meeting Approves All Proposals 4/18/2013  More...
BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4/18/2013  More...
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) to Report First Quarter 2013 Financial Results on April 24, 2013; Conference Call to Follow 4/18/2013  More...
Elan Corporation PLC (ELN) Announces Final Results of Its Tender Offer 4/18/2013  More...
Targeted Medical Pharma Announces Registration Statement 4/18/2013  More...
Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering 4/17/2013  More...
Lignol Announces 40% Stake in Territory Biofuels Limited 4/17/2013  More...
Trading in Theravance, Inc. (THRX) Common Stock Halted 4/17/2013  More...
Ablynx: Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (the "Transparency Law") 4/17/2013  More...
Recordati S.p.A: Shareholders Approve the 2012 Accounts. Dividend EUR 0.30 Per Share 4/17/2013  More...
Abiomed (ABMD) Announces Preliminary Fourth Quarter Revenue of $43.7 Million, Driven by Record Number of Patients Supported 4/17/2013  More...
WuXi PharmaTech Co., Ltd. Files 2012 Annual Report on Form 20-F 4/17/2013  More...
MorphoSys AG: Announcement of the Convening of the AGM in Munich/Germany on 4 June 2013 According to Sec. 121 Para. 4a AktG With the Objective of Europe-Wide Distribution 4/16/2013  More...
The Special Committee of China Shenghuo Pharmaceutical Holdings, Inc. Accepts Going Private Proposal From Lan's Int'l Medicine Investment Co., Limited at $0.16 per Share to be Effected Through a Reverse Stock Split 4/16/2013  More...
Gestion Notify of 4.97% Shareholding in Galapagos NV (GLPG.BR) 4/15/2013  More...
Novo Nordisk A/S (NVO) - Share Repurchase Program 4/15/2013  More...
BioRestorative Therapies, Inc. Announces One-for-Fifty Reverse Stock Split 4/15/2013  More...
CorMedix (CRMD) Notified of NYSE MKT Listing Deficiency 4/12/2013  More...
Actavis to Host First Quarter 2013 Earnings Conference Call and Webcast 4/11/2013  More...
Boston Scientific Corporation (BSX) to Webcast Conference Call Discussing First Quarter 2013 Financial Results on April 25 4/11/2013  More...
Incyte Corporation (INCY) to Report First Quarter 2013 Financial Results on May 2 4/11/2013  More...
IGI Laboratories, Inc. to Hold Conference Call for 1st Quarter 2013 Results 4/11/2013  More...
Webcast Alert: Heska Corporation (HSKA) Announces First Quarter 2013 Earnings Conference Call Webcast 4/11/2013  More...
Cardinal Health, Inc. (CAH) to Release Third-Quarter Results For Fiscal Year 2013 on May 2 4/11/2013  More...
Medical Marijuana, Inc. Reports Record First Quarter 2013 Revenue and Income 4/11/2013  More...
Alexion Pharmaceuticals Inc. (ALXN) to Report First Quarter 2013 Results on Thursday, April 25, 2013 4/11/2013  More...
TRT Chinese Medicines Expects to IPO on ChiNext 4/11/2013  More...
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at Regen Med Investor Day 4/11/2013  More...
AptarGroup Declares Quarterly Dividend; Confirms First Quarter Conference Call 4/11/2013  More...
Active Biotech AB (BTPC) - Notice of Annual General Meeting of Shareholders 4/11/2013  More...
Sunshine Heart Prices $13.1 Million Public Offering of Common Shares 4/11/2013  More...
OXiGENE (OXGN) Announces $5 Million Private Placement 4/11/2013  More...
Active Biotech AB (BTPC) - Notice of Annual General Meeting of Shareholders 4/11/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) to Report First Quarter 2013 Financial Results on May 2, 2013 4/10/2013  More...
Hill-Rom Holdings, Inc. to Host Investor Conference May 7 4/10/2013  More...
WuXi PharmaTech Co., Ltd. Schedules First-Quarter 2013 Earnings Release 4/10/2013  More...
Charles River Laboratories (Massachusetts) Schedules First-Quarter 2013 Earnings Release and Conference Call 4/9/2013  More...
Biostar Pharmaceuticals, Inc. (BSPM) to Host Fiscal 2012 Year End Earnings Conference Call on Monday, April 15, 2013 at 9:30 a.m. ET 4/9/2013  More...
Mylan Inc. (MYL) Schedules First Quarter 2013 Financial Results Conference Call and Live Webcast 4/9/2013  More...
NxStage Medical, Inc. (NXTM) to Report First Quarter Fiscal 2013 Financial Results 4/9/2013  More...
Hadasit Bio-Holdings Ltd.  (HDST) CEO Letter to Shareholders 4/9/2013  More...
Organovo Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 4/9/2013  More...
Northwest Biotherapeutics (NWBT) 2012 Annual Report Shows Strong Progress and Enhancement of Leadership Position 4/9/2013  More...
Galapagos NV (GLPG.BR) Increases Share Capital Through Warrant Exercises 4/9/2013  More...
Illumina, Inc. (ILMN) to Announce First Quarter 2013 Financial Results on Monday, April 22, 2013 4/8/2013  More...
AmerisourceBergen Corporation (ABC) Announces Date and Time for Fiscal Second Quarter Earnings Release 4/8/2013  More...
AbbVie (ABBV) to Host First-Quarter Earnings Conference Call 4/8/2013  More...
Novo Nordisk A/S (NVO) - Share Repurchase Program 4/8/2013  More...
Oragenics, Inc. (OGEN) Announces Approval of Common Stock Listing on NYSE MKT 4/8/2013  More...